Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2013
10/22/2013CA2602776C Method for treating prostate diseases based on local delivery of active substances
10/22/2013CA2582045C Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
10/22/2013CA2580981C Stabilized human igg4 antibodies
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/17/2013WO2013155465A1 Substituted xanthine derivatives
10/17/2013WO2013155371A1 MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCER
10/17/2013WO2013154794A1 Trans 10 : ci s 12 isomer of conjugated linoleic acid as a therapeutic and preventative agent for pregnancy induced hypertension or preeclampsia
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/17/2013US20130273042 Treatment of multiple sclerosis
10/16/2013EP2648756A2 Targeting kidney mesangium with nanoparticles of defined diameter
10/16/2013CN103354745A Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
10/16/2013CN103351985A Low-degree health care liquor and preparation method thereof
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN103349751A Mongolian medicine composition for treating diabetic nephropathy and preparation method thereof
10/16/2013CN103349730A Medicine for treating kidney heat and preparation method of medicine
10/16/2013CN103349724A Anemarrhenae rhizoma total flavone extract and method for concurrently preparing anemarrhenae rhizoma total flavone extract and anemarrhenae rhizoma total saponin extract
10/16/2013CN103349720A Traditional Chinese medicine composition for treating acute cystitis
10/16/2013CN103349715A Medicine for treating kidney stone
10/16/2013CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof
10/16/2013CN103349664A Steroidal c- 17 benzoazoles
10/16/2013CN103349656A Valsartan capsule and preparation method thereof
10/16/2013CN103006891B Medicine composition for treating chronic renal failure
10/16/2013CN102895550B Traditional Chinese medicine for treating glomerulonephritis
10/16/2013CN102813837B Preparation method of traditional Chinese medicine for treating blood pressure rising type acute glomerulonephritis
10/16/2013CN102793903B Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis
10/16/2013CN102698057B Medicine for treating bladder tumor
10/16/2013CN102614108B Cubic water quality liquid crystal gel transdermic absorption preparation containing oxybutynin chloride and preparing method thereof
10/16/2013CN102579676B Chinese herbal compound preparation for treating chronic abacterial prostatitis
10/16/2013CN102307579B Pharmaceutical composition for oral administration
10/16/2013CN102030709B Benzazepines compounds serving as vasopressin receptor antagonism
10/16/2013CN101952249B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
10/16/2013CN101605905B Method for glycosylation of flavonoid
10/15/2013US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
10/15/2013US8557796 Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods
10/15/2013CA2628476C Pharmaceutical for use in the treatment of ureterolithiasis
10/15/2013CA2522319C N-[(piperazinyl)hetaryl]arylsulfonamide compounds and derivatives thereof with affinity for the dopamine d3 receptor
10/15/2013CA2410762C Feline hepatocyte growth factor
10/10/2013WO2013150382A1 Herbal compositions for the prevention or treatment of benign prostatic hyperplasia and related disorders
10/10/2013WO2013149997A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013066879A3 SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE
10/10/2013WO2013054337A9 Extended release pharmaceutical compositions of fesoterodine
10/10/2013US20130266553 Albumin Fusion Proteins
10/09/2013EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound
10/09/2013EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013EP2647628A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013CN103343160A Novel purpose of microRNA-30 family
10/09/2013CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases
10/09/2013CN103341127A Traditional Chinese medicine for treating uremia along with hematodialysis and preparation method
10/09/2013CN103341108A Pharmaceutical composite for treating stress urinary incontinence after prostatectomy
10/09/2013CN103341107A Chinese medicine composition for treating enuresis
10/09/2013CN103341095A Clysis liquid used for chronic renal failure
10/09/2013CN103341082A Application of Chinese medicine composition in preparation of medicine used for treating hypertension and proteinuria
10/09/2013CN103341081A Traditional Chinese medicine composition for treating hypertension and proteinuria
10/09/2013CN103341071A Traditional Chinese medicine composition for treating canine and feline urocystitis and preparation method thereof
10/09/2013CN103341064A Chinese medicine composition for treating urine retention
10/09/2013CN103341059A Chinese medicine composition for treating non-gonococcal urethritis
10/09/2013CN103341057A Chinese patent medicine pill for treating calculus, nephritis and cholecystitis
10/09/2013CN103341016A Traditional Chinese medicine
10/09/2013CN103340982A Wolfberry powder tablet and preparation method thereof
10/09/2013CN103340978A Chinese and western combination drug for treating frequent micturition and urgent urination
10/09/2013CN103340957A Chinese herbal medicine compound for resisting fatigue of human body, nourishing kidneys and tonifying yang
10/09/2013CN103340877A Application of Aspeverin in preparation of medicine for treating acute renal failure
10/09/2013CN103340850A Application of Aphanamgrandiol A in preparation of drugs for treating acute renal failure
10/09/2013CN103340845A 药物组合物 The pharmaceutical composition of
10/09/2013CN103340844A Application of gamatine in preparing drug resisting high PTH
10/09/2013CN102727830B Traditional Chinese medicine calculus removing capsules
10/09/2013CN102657763B Externally used composition for treating mumps, lymphnoditis or prostatitis
10/09/2013CN102488743B Chinese traditional medicine composition, preparation method thereof and Chinese traditional medicine preparation
10/08/2013US8552196 Apoptosis signal-regulating kinase inhibitors
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/08/2013US8551951 Pharmaceutical preparations and methods for inhibiting tumors
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013CA2473938C Human adam-10 inhibitors
10/03/2013WO2013148285A1 Methods of inhibiting cell proliferation
10/03/2013WO2013147458A1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process
10/03/2013WO2013147161A1 Nipecotic acid derivative and use thereof for medical purposes
10/03/2013WO2013147134A1 Mirabegron-containing pharmaceutical composition
10/03/2013WO2013147076A1 FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN α8β1 FUNCTION
10/03/2013WO2013147072A1 Cocrystal of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one
10/03/2013WO2013146754A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity
10/03/2013US20130259901 Neuropeptide Y Treatment of Autoimmune Disease
10/03/2013CA2875200A1 Fibrosis suppression by inhibiting integrin alpha8beta1 function
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013CN103333218A 3 alpha,11 alpha-dihydroxy-lupin-20(29)-alkene-28-acid with anti-inflammatory effect and preparation method thereof
10/02/2013CN103333138A Novel Cabazitaxel crystal form, preparation method, application and pharmaceutical compositions thereof
10/02/2013CN103330897A Pharmaceutical composition for treating renal and ureteral calculus
10/02/2013CN103330876A Decoction for curing cystitis
10/02/2013CN103330868A Intestinal tract replenishing liquid for chronic renal failure
10/02/2013CN103330864A Traditional Chinese medicine composition used for treating acute?nephritis and preparation method thereof
10/02/2013CN103330846A Traditional Chinese medicine for treating nephrotic syndrome
10/02/2013CN103330796A Pharmaceutical composition for treating cardiorenal syndrome
10/02/2013CN103330779A Traditional Chinese medicine composition capable of quickly resolving kidney stone
10/02/2013CN103330715A Peritoneal dialysis solution for resisting fibration of peritonaeum
10/02/2013CN103330704A Application of Aphanamgrandiol A in preparation of drugs treating renal insufficiency
10/02/2013CN102813848B Preparation method of traditional Chinese medicine for treating vomit type acute glomerulonephritis
10/02/2013CN102813822B Preparation method of traditional Chinese medicine for treating pain type acute glomerulonephritis
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 562